BioCryst Pharmaceuticals reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
BioCryst Pharmaceuticals 0 0 Mar/2025
Chugai Pharma 1.42 0.12 Mar/2026
Daiichi Sankyo 2.06 0.25 Dec/2025
DBV Technologies USD 0 0 Aug/2024
Enanta Pharmaceuticals 0 0 Mar/2025
Gilead Sciences 2.29 0.29 Mar/2026
GlaxoSmithKline 0.82 3.75 Mar/2026
Glaxosmithkline GBP 4.47 0.32 Dec/2025
Karyopharm Therapeutics 0 0 Mar/2025
Regeneron Pharmaceuticals 0.46 0.01 Mar/2026
Roche Holding 2.96 0.8 Dec/2025